Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population-Reference-Cited by-同舟云学术

Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population

Published:2014-10 Issue:44 Volume:32 Page:5816-5823
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Atsmon Jacob,Caraco Yoseph,Ziv-Sefer Sagit,Shaikevich Dimitry,Abramov Ester,Volokhov Inna,Bruzil Svetlana,Haima Kirsten Y.,Gottlieb Tanya,Ben-Yedidia Tamar

Funder

BiondVax Pharmaceuticals Ltd (Israel)

Office of Israeli Chief Scientist

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. Centers for Disease Control and Prevention (CDC). Estimated influenza illnesses and hospitalizations averted by influenza vaccination—United States, 2012–2013 influenza season. Morbidity and Mortality Weekly Report 2013;62(49):997–1000.

2. Challenges for vaccination in the elderly;Aspinall;Immun. Ageing,2007

3. Biology of immune responses to vaccines in elderly persons;Weinberger;Clin. Infect. Dis.,2008

4. Antibody response to influenza vaccination in the elderly: a quantitative review;Goodwin;Vaccine,2006

5. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach;Lambert1;Expert Rev. Vaccin.,2012

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections;Vaccines;2024-04-29

2. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines;Influenza and Other Respiratory Viruses;2024-03

3. Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines;Vaccines;2023-11-23

4. Capillary electrophoresis in the analysis of therapeutic peptides—A review;ELECTROPHORESIS;2023-09-14

5. Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults – A randomized clinical trial;Vaccine;2023-04